Published in N Engl J Med on January 01, 1970
Rapid method for identification of gram-negative, nonfermentative bacilli. J Clin Microbiol (1976) 3.24
Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl Microbiol (1972) 2.47
Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water. Appl Microbiol (1973) 2.05
Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol (1971) 2.01
In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother (1972) 1.82
Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother (1992) 1.50
Characterization of some groups of gram-negative nonfermentative bacteria by the carbon source alkalinization technique. J Clin Microbiol (1981) 1.37
Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers. J Clin Microbiol (1976) 1.29
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother (2007) 1.23
Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride. Appl Environ Microbiol (1979) 1.22
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
Causes and prevention of sepsis due to Gram-negative bacteria. Common-source outbreaks. Proc R Soc Med (1971) 1.15
Characterization of EO-1 strains (Pseudomonas kingii) isolated from clinical specimens and the hospital environment. Appl Microbiol (1970) 1.15
Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability. Antimicrob Agents Chemother (1989) 1.14
Resistance of Pseudomonas to quaternary ammonium compounds. II. Cross-resistance characteristics of a mutant of Pseudomonas aeruginosa. Appl Microbiol (1971) 1.09
Organisms encountered in urine cultures over a 10-year period. Appl Microbiol (1972) 1.04
Pseudomonas cepacia colonization and infection in intensive care units. CMAJ (1986) 1.01
Pseudomonas cepacia septic arthritis due to intra-articular injections of methylprednisolone. Can Med Assoc J (1977) 0.92
Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis. Hawaii J Med Public Health (2013) 0.79
Pseudomonas cepacia septicemia associated with intravenous therapy. Calif Med (1973) 0.78
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
Rapid hippurate hydrolysis method for presumptive identification of group B streptococci. J Clin Microbiol (1975) 10.70
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49
Comparative study of the efficacy of seven paper-reagent strips and conventional biochemical tests in identifying gram-negative organisms. Appl Microbiol (1969) 8.23
Comparison of micro-ID, API 20E, and conventional media systems in identification of Enterobacteriaceae. J Clin Microbiol (1978) 7.65
Comparison of macroscopic examination, routine gram stains, and routine subcultures in the initial detection of positive blood cultures. Appl Microbiol (1974) 7.33
Effect of aerobic and anaerobic atmospheres on isolation of organisms from blood cultures. J Clin Microbiol (1975) 5.23
Rapid extraction method with pronase B for grouping beta-hemolytic streptococci. Appl Microbiol (1972) 4.61
Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1969) 4.12
Rapid semiautomated screening and processing of urine specimens. J Clin Microbiol (1980) 3.01
Characterization of ornithine decarboxylase-positive, nonmotile strains of the Klebsiella-Enterobacter group. Appl Microbiol (1969) 2.99
Colonization and infection with Pseudomonas cepacia. J Infect Dis (1972) 2.91
Microwave oven irradiation as a method for bacterial decontamination in a clinical microbiology laboratory. J Clin Microbiol (1977) 2.76
Simplified fluorescent-antibody staining method for primary plate isolates of group A streptococci. Appl Microbiol (1972) 2.74
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Evaluation of the PathoTec "Rapid I-D System". Appl Microbiol (1973) 2.54
Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother (1973) 2.51
Evaluation of an adenosine 5'-triphosphate assay as a screening method to detect significant bacteriuria. J Clin Microbiol (1976) 2.48
Rapid identification of group B streptococci by counterimmunoelectrophoresis. J Clin Microbiol (1975) 2.45
Rapid detection of yeast enzymes by using 4-methylumbelliferyl substrates. J Clin Microbiol (1981) 2.39
Characterization of Klebsiella isolates from natural receiving waters and comparison with human isolates. Appl Microbiol (1974) 2.37
Rapid screening for bacteriuria by light scatter photometry (Autobac): a collaborative study. J Clin Microbiol (1981) 2.28
Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24
Quality control testing with disk antibiotic susceptibility test of Bauer-Kirby-Sherris-Turck. Am J Clin Pathol (1972) 2.23
Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12
Motility-indole-ornithine medium. Appl Microbiol (1970) 1.94
Prevalence and characteristics of Klebsiella species: relation to association with a hospital environment. J Infect Dis (1974) 1.94
Epidemic viral hepatitis, type B, in hospital personnel. Am J Med (1974) 1.87
Nosocomial colonization with Klebsiella, type 26, in a neonatal intensive-care unit associated with an outbreak of sepsis, meningitis, and necrotizing enterocolitis. J Pediatr (1974) 1.78
Comparison and evaluation of carbenicillin disks in diffusion susceptibility testing. Antimicrob Agents Chemother (1974) 1.75
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluation. J Clin Microbiol (1982) 1.68
Laboratory evaluation of urinary tract infections in an ambulatory clinic. Am J Clin Pathol (1994) 1.58
Computer-assisted bacterial identification utilizing antimicrobial susceptibility profiles generated by autobac 1. J Clin Microbiol (1976) 1.56
An evaluation of the practicality of the spot-indole test for the identification of Escherichia coli in the clinical microbiology laboratory. Am J Clin Pathol (1982) 1.52
Novel approach to bacterial identification that uses the autobac system. J Clin Microbiol (1982) 1.50
Time-motion and cost comparison study of micro-ID, API 20E, and conventional biochemical testing in identification of Enterobacteriaceae. J Clin Microbiol (1981) 1.48
Klebsiella type 33 septicemia in an infant intensive care unit. J Pediatr (1972) 1.37
Viability of organisms held in the isolator blood culture system for 15 h and their rapid detection by acridine orange staining. J Clin Microbiol (1983) 1.35
Automated, rapid identification of bacteria by pattern analysis of growth inhibition profiles obtained with Autobac 1. J Clin Microbiol (1977) 1.34
Collaborative clinical evaluation of the Autobac IDX system for identification of gram-negative bacilli. J Clin Microbiol (1984) 1.30
Incidence and identification of Pseudomonas fluorescens and Pseudomonas putida in the clinical laboratory. Appl Microbiol (1973) 1.30
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories. J Clin Microbiol (1984) 1.30
A longitudinal study of Sin Nombre virus prevalence in rodents, southeastern Arizona. Emerg Infect Dis (1999) 1.28
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae. J Infect Dis (1976) 1.27
Infections with Providence bacilli. A clinical and bacteriologic study. Am J Med (1971) 1.26
Carbenicillin therapy of severe Pseudomonas aeruginosa infections. J Chronic Dis (1971) 1.25
Detection of arginine dihydrolase in nonfermentative gram-negative bacteria by use of thin-layer chromatography. Appl Microbiol (1971) 1.24
Biochemical and antibiotic susceptibility studies of H2S-negative Citrobacter. Appl Microbiol (1974) 1.21
Review of urine microscopy for bacteriuria. JAMA (1986) 1.20
In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 1.19
Piperacillin pharmacokinetics in subjects with chronic renal failure. Antimicrob Agents Chemother (1981) 1.18
Evaluation of a new incubation-type indole strip test. Appl Microbiol (1970) 1.18
Susceptibility of anaerobic bacteria to carbenicillin. Antimicrob Agents Chemother (1974) 1.17
Familial neuroblastoma: report of a kindred with a high incidence of infantile tumors. J Pediatr (1972) 1.14
Bioassay of antibiotics in body fluids from patients receiving cancer chemotherapeutic agents. Antimicrob Agents Chemother (1980) 1.14
Evaluation of bacteriological transport media. Am J Med Technol (1973) 1.13
In vitro activity of aztreonam combined with tobramycin and gentamicin against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis. Antimicrob Agents Chemother (1987) 1.13
Ten-minute test for differentiating between Klebsiella and Enterobacter isolates. Appl Microbiol (1970) 1.13
Characterization of indole-positive Proteus mirabilis. Appl Microbiol (1972) 1.13
Optimal bacitracin concentration for selective isolation medium for haemophilus. Am J Med Technol (1971) 1.10
Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis. Am J Med (1987) 1.08
Evaluation of a rapid bacteriuria screening instrument. Diagn Microbiol Infect Dis (1984) 1.07
Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06
Evaluation of the Wayson variation of a methylene blue staining procedure for the detection of microorganisms in cerebrospinal fluid. J Clin Microbiol (1985) 1.05
Organisms encountered in urine cultures over a 10-year period. Appl Microbiol (1972) 1.04
Carbon monoxide production from heme compounds by bacteria. J Bacteriol (1972) 1.03
Rapid test for urease and phenylalanine deaminase production. Appl Microbiol (1971) 0.99
In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin. Am J Clin Pathol (1980) 0.99
False susceptibility of enterococci to aminoglycosides with blood-enriched Mueller-Hinton agar for disk susceptibility testing. J Clin Microbiol (1985) 0.98
Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother (1982) 0.96
Host factors and capsular typing of body fluid isolates in fulminant pneumococcal infections. Infect Immun (1972) 0.95
Rapid identification of swarming Proteus using the PathoTec ornithine decarboxylase test strip. J Clin Microbiol (1975) 0.95
Device for turbidity standardizing of cultures for antibiotic sensitivity testing. Appl Microbiol (1970) 0.94
Proteus mirabilis osteomyelitis in two neonates following needle puncture. Successful treatment with ampicillin. Am J Dis Child (1973) 0.94
Rapid identification by the Micro-ID system of Enterobacteriaceae detected by urine screening. J Clin Microbiol (1981) 0.94
Infectious complications in bone marrow transplant patients. Br Med J (1971) 0.93
Identification of Pseudomonas aeruginosa by pyocyanin production on Tech agar. J Clin Microbiol (1981) 0.93
Motility-indole-lysine-sulfide medium. J Clin Microbiol (1975) 0.92
Clindamycin therapy of staphylococcal pulmonary infections in patients with cystic fibrosis. J Pediatr (1981) 0.91
Cephaloglycin in pediatric patients. Am J Dis Child (1971) 0.91
The sources of hospital infection. Medicine (Baltimore) (1973) 0.91
Use of the Bac-T-Screen to predict bacteriuria from urine specimens held at room temperature. J Clin Microbiol (1986) 0.91
Laminar airflow protection in bone marrow transplantation. Appl Microbiol (1971) 0.90
Enzyme-linked immunosorbent assay and radioimmunoassay in the serologic diagnosis of infectious diseases. J Infect Dis (1983) 0.90
Relationship of indole production and antibiotic susceptibility in the Klebsiella bacillus. J Clin Microbiol (1975) 0.90
The scalp-vein needle. A prospective study of complications. JAMA (1972) 0.89
Counterimmunoelectrophoresis and bacterial meningitis. JAMA (1978) 0.89
Cefoperazone pharmacokinetics in preterm infants. Antimicrob Agents Chemother (1983) 0.89
In vitro activities of combinations of aztreonam, ciprofloxacin, and ceftazidime against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis. Antimicrob Agents Chemother (1990) 0.89
Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients. Antimicrob Agents Chemother (1982) 0.88
Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients. Antimicrob Agents Chemother (1991) 0.87
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters. Antimicrob Agents Chemother (1990) 0.87
Carbon monoxide production from hydroxocobalamin by bacteria. Biochim Biophys Acta (1973) 0.87
Evaluation of urine culture screening by light-scatter photometry. Am J Clin Pathol (1981) 0.86
Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics. Antimicrob Agents Chemother (1989) 0.85
Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children. Pediatr Infect Dis (1983) 0.85